Fluoroquinolones, a popular antibiotic class that inhibits nucleic acid synthesis of bacteria by disrupting the activity of the enzyme’s topoisomerase IV and DNA gyrase, are used to treat bacterial infections. This evidence concerns the gene TOP2A and bacterial infectious disease.